After a cacophony of troubles hit the RNA editing biotech last fall, CEO Ram Aiyar is in San Francisco to develop ...

Few companies stand better poised than Beam Therapeutics to reap the first fruits of the FDA’s promised flexibility toward cell and gene therapies. | Riding a regulatory win for its base editing ...

Program to feature presentations from the company management about KRRO-121 for the potential treatment of hyperammonemia, a leading clinical ...

Korro Bio, Inc. ( KRRO) 44th Annual J.P. Morgan Healthcare Conference January 15, 2026 1:30 PM EST ...

Genome Editing Market Genome Editing Market Dublin, Jan. 22, 2026 (GLOBE NEWSWIRE) -- The "Genome Editing Market - Global ...

Picture CRISPR-Cas9, a gene editing technology, as a GPS-guided scalpel: gRNA directs the Cas9 enzyme, a protein that cuts ...

MoneyShow presents top investment ideas for 2026 from leading advisors. Part 9 includes Target Corp., The Trade Desk, UFP ...

Nature’s annual list of technologies to watch is a chance to celebrate progress and stimulate research into both ...

Explore RNA interference methods, comparing siRNA and shRNA for gene knockdown, their mechanisms, advantages, and ...

In Regents of the University of California v. Broad Institute, Inc., the Federal Circuit addressed the issue of conception and reduction to ...

BEIJING, Jan. 20, 2026 /PRNewswire/ -- Beijing Tsingke Biotech Co., Ltd., a leading biotechnology company, today announced ...

Researchers have identified OTULIN, an immune-regulating enzyme, as a key trigger of tau buildup in the brain. When OTULIN ...